The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey
- PMID: 34128108
- PMCID: PMC8203210
- DOI: 10.1007/s00520-021-06324-4
The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey
Abstract
Background: The COVID-19 pandemic required reevaluation of the therapeutic approach and added emotional stress for patients with hematological malignancies at high risk of contracting the virus. We aimed to evaluate how it affected such patients during the second lockdown in Israel.
Methods: This national survey included Hebrew-speaking patients with hematological malignancy. This included three tools with 28 items of sociodemographic and medical baseline characteristics, management of hematological disease, and evaluation of emotional coping during COVID-19 pandemic; the Hebrew version of the Patient Health Questionnaire 9; and 3 qualitative open-ended questions. Data was analyzed by mixed methods which combined both quantitative and qualitative thematic analyses.
Results: Four hundred eight patients responded to the survey. The management of their hematological disease included a decrease in the number of visits to the hematology clinic (37.0%), delay of some treatment schedules (9.1%), and prescription of replacement therapies permitting less visits to the clinic (2.2%). The frequency and intensity of "feeling afraid" regarding COVID-19 infection was increased (mean ± SD: 4 ± 1 to 5 ± 2 in a 1-7 Likert scale), and a high rate of depression was recorded, which appeared to be more evident in patients with chronic myeloid leukemia (CML) (p < 0.001).
Conclusion: The management of hematological malignancies during pandemics should always take into consideration patients' fears, as well as the development of depression related to isolation and loneliness, in addition to the high risk of severe disease. Patients with CML had a high rate of depression which obviously needs to be managed very carefully during and after the COVID-19 pandemic.
Keywords: COVID-19; Coping; Depression; Hematological malignancies; Mixed methods; Survey.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic.Turk J Med Sci. 2021 Dec 13;51(6):2799-2809. doi: 10.3906/sag-2101-276. Turk J Med Sci. 2021. PMID: 33705648 Free PMC article. Review.
-
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).J Hematol Oncol. 2021 Oct 14;14(1):168. doi: 10.1186/s13045-021-01177-0. J Hematol Oncol. 2021. PMID: 34649563 Free PMC article. Clinical Trial.
-
Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality.Eur J Haematol. 2023 Jul;111(1):135-145. doi: 10.1111/ejh.13977. Epub 2023 Apr 24. Eur J Haematol. 2023. PMID: 37096337
-
The management of hematologic malignancies during the COVID-19 pandemic.Expert Opin Pharmacother. 2021 Apr;22(5):565-582. doi: 10.1080/14656566.2020.1849143. Epub 2020 Dec 21. Expert Opin Pharmacother. 2021. PMID: 33342308 Review.
-
COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.Leuk Lymphoma. 2022 Mar;63(3):664-671. doi: 10.1080/10428194.2021.1992626. Epub 2021 Oct 20. Leuk Lymphoma. 2022. PMID: 34668809
Cited by
-
Haematological malignancies implications during the times of the COVID-19 pandemic.Oncol Lett. 2021 Dec;22(6):856. doi: 10.3892/ol.2021.13117. Epub 2021 Oct 29. Oncol Lett. 2021. PMID: 34777590 Free PMC article. Review.
-
Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients.Vaccines (Basel). 2024 Feb 8;12(2):174. doi: 10.3390/vaccines12020174. Vaccines (Basel). 2024. PMID: 38400157 Free PMC article.
-
Incidence of symptomatic Covid-19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population.Eur J Haematol. 2023 Jan;110(1):67-76. doi: 10.1111/ejh.13875. Epub 2022 Oct 17. Eur J Haematol. 2023. PMID: 36193973 Free PMC article.
-
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection.Cancers (Basel). 2022 Feb 24;14(5):1173. doi: 10.3390/cancers14051173. Cancers (Basel). 2022. PMID: 35267478 Free PMC article.
-
COVID-19 in patients with hematologic malignancy.Blood. 2022 Jul 21;140(3):236-252. doi: 10.1182/blood.2021012251. Blood. 2022. PMID: 35544585 Free PMC article.
References
-
- Staff T. Ministers agree on full lockdown, more severe than Israel’s first. The Times of Israel. https://www.timesofisrael.com/ministers-said-to-agree-on-full-lockdown-m.... Published 2020
MeSH terms
LinkOut - more resources
Full Text Sources
Medical